Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.

NCT07068490 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07068490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07068490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Recruiting
Start date
October 22, 2024
Completion date
December 31, 2025
Enrollment
100,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease